News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Local

Snuff the Butt at UI Tailgate Parties

cigarette butt

Enforcement still up in the air

in Local

Decatur Asian Carp Screen Back in Place

Lake Decatur

Bad winter weather damaged screen

in Local

Medical Marijuana Applications Posted for Business

marijuana

Applications for medical marijuana begins September 2 for patients, September 8 for dispensaries.

in Local

Illinois Museum to Display 1916 Military Equipment

ihpa logo

Military equipment from 1916 to be on display starting September 6.

in Local

Reaction to IDNR’s Long-Awaited Fracking Rules Proposal

frack

One expert laments the length of time it took DNR to write the rules, which he says are too restrictive. Meanwhile, another expert says she'll have to see what the rules are before she calls them restrictive.